Bile Duct Neoplasms also known as Biliary Tract Cancer is a rare and heterogeneous malignant neoplasm with epithelial cell origin of biliary duct and histologic and biochemical features of cholangiocyte differentiation.
The malignant tumor may arise from any portion of the bile duct i.e., from terminal ductules (canals of Hering) to the ampulla of Vater, as well as at the peribiliary glands (intramural and extramural) and sometimes may affect gallbladder. Inflammation, cholestasis and receptor tyrosine kinases such as IL-6 receptor, c-MET and the EGFR family members are key signaling pathways in cholangiocarcinogenesis.
Hitherto, surgical treatments are the only potentially curative therapeutic options for all the subtypes of CCA. However, the majority of CCA patients are diagnosed at late stage disease, and nearly more than one-fourth of patients considered resectable are found to be unresectable during explorative laparotomy.
DelveInsight’s “Bile Duct Neoplasms Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Bile Duct Neoplasms, historical and forecasted epidemiology as well as the Bile Duct Neoplasms market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the Bile Duct Neoplasms Facts:
Request for free Sample Report: https://www.delveinsight.com/sample-request/bile-duct-neoplasms-market
Scope of the Bile Duct Neoplasms Report:
Key Bile Duct Neoplasms companies Covered:
Bile Duct Neoplasms Drugs Covered:
Table of Contents:
1. Key Insights
2. Executive Summary of Bile Duct Neoplasms
3. Competitive Intelligence Analysis for Bile Duct Neoplasms
4. Bile Duct Neoplasms: Market Overview at a Glance
5. Bile Duct Neoplasms: Disease Background and Overview
6. Patient Journey
7. Bile Duct Neoplasms Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Bile Duct Neoplasms Treatment
11. Marketed Products
12. Emerging Therapies
13. Bile Duct Neoplasms: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Bile Duct Neoplasms
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Request for Detailed TOC: https://www.delveinsight.com/sample-request/bile-duct-neoplasms-market
About DelveInsight DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/bile-duct-neoplasms-market